NCT03029806

Brief Summary

The purpose of this study is to investigate the role dietary salt plays in epigenetic regulation of blood pressure, focusing on the salt-sensitive regulatory enzyme Lysine-specific demethylase 1.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2017

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

January 20, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 24, 2017

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2022

Completed
4.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

5 years

First QC Date

January 20, 2017

Last Update Submit

November 18, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Aldosterone response to angiotensin II

    Change in aldosterone, baseline to after angiotensin II by genotype/race

    After 1 week dietary salt manipulation

Secondary Outcomes (2)

  • Renal blood flow response to dietary salt

    After 1 week dietary salt manipulation on both diets

  • Vascular stiffness response to angiotensin II

    After 1 week dietary salt manipulation

Study Arms (4)

Afr-Amer risk allele

ACTIVE COMPARATOR

African Americans carrying the LSD1 affected allele

Other: Aldosterone response to AngII LSOther: Renal blood flow response to saltOther: Vascular Stiffness

Cauc risk allele

PLACEBO COMPARATOR

Caucasians carrying the LSD1 affected allele

Other: Aldosterone response to AngII LSOther: Renal blood flow response to saltOther: Vascular Stiffness

Afr-Amer non-risk allele

PLACEBO COMPARATOR

African Americans carrying the LSD1 non-risk allele

Other: Aldosterone response to AngII LSOther: Renal blood flow response to saltOther: Vascular Stiffness

Cauc non-risk allele

PLACEBO COMPARATOR

Caucasians carrying the LSD1 non-risk allele

Other: Aldosterone response to AngII LSOther: Renal blood flow response to saltOther: Vascular Stiffness

Interventions

Change in aldosterone from baseline to after Ang II infusion on a LS diet

Afr-Amer non-risk alleleAfr-Amer risk alleleCauc non-risk alleleCauc risk allele

Change in renal blood flow: High salt to low salt diet

Afr-Amer non-risk alleleAfr-Amer risk alleleCauc non-risk alleleCauc risk allele

Change in vascular stiffness, baseline compared to AngII

Afr-Amer non-risk alleleAfr-Amer risk alleleCauc non-risk alleleCauc risk allele

Eligibility Criteria

Age25 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 25-45 years
  • Caucasian or African American
  • No gender preference (anticipate 50% female)
  • Normotensive (screening blood pressure \<140/90 mmHg)
  • No history of hypertension, diabetes, stroke, coronary artery disease, kidney disease, cancer, thyroid disease, preeclampsia, or hospitalizations in 6 months
  • Normal screening laboratory values (CMP, TSH, A1c)
  • Normal ECG
  • BMI \<25 kg/m2

You may not qualify if:

  • Pregnancy
  • Breast feeding
  • Any medication or herbal preparation
  • \>6oz alcohol/week
  • Tobacco use
  • Illicit drug use
  • Chronic NSAID use
  • Recent steroid use (injected, inhaled, oral)
  • Decongestant use in the past 2 weeks
  • Known sensitivity to infused Angiotensin II or para-amino hippurate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Related Publications (4)

  • Krug AW, Tille E, Sun B, Pojoga L, Williams J, Chamarthi B, Lichtman AH, Hopkins PN, Adler GK, Williams GH. Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake. Age (Dordr). 2013 Oct;35(5):1809-20. doi: 10.1007/s11357-012-9480-0. Epub 2012 Oct 2.

    PMID: 23054827BACKGROUND
  • Williams JS, Chamarthi B, Goodarzi MO, Pojoga LH, Sun B, Garza AE, Raby BA, Adler GK, Hopkins PN, Brown NJ, Jeunemaitre X, Ferri C, Fang R, Leonor T, Cui J, Guo X, Taylor KD, Ida Chen YD, Xiang A, Raffel LJ, Buchanan TA, Rotter JI, Williams GH, Shi Y. Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension. Am J Hypertens. 2012 Jul;25(7):812-7. doi: 10.1038/ajh.2012.43. Epub 2012 Apr 26.

    PMID: 22534796BACKGROUND
  • Pojoga LH, Williams JS, Yao TM, Kumar A, Raffetto JD, do Nascimento GR, Reslan OM, Adler GK, Williams GH, Shi Y, Khalil RA. Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension. Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H1862-71. doi: 10.1152/ajpheart.00513.2011. Epub 2011 Aug 26.

    PMID: 21873498BACKGROUND
  • Heydarpour M, Parksook WW, Pojoga LH, Williams GH, Williams JS. Mineralocorticoid Receptor and Aldosterone: Interaction Between NR3C2 Genetic Variants, Sex, and Age in a Mixed Cohort. J Clin Endocrinol Metab. 2024 Dec 18;110(1):e140-e149. doi: 10.1210/clinem/dgae127.

MeSH Terms

Interventions

Vascular Stiffness

Intervention Hierarchy (Ancestors)

Cardiovascular Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Heathy volunteers
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Physician, Brigham and Women's Hospital

Study Record Dates

First Submitted

January 20, 2017

First Posted

January 24, 2017

Study Start

January 2, 2017

Primary Completion

January 2, 2022

Study Completion (Estimated)

June 1, 2026

Last Updated

November 21, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

IPD will be shared first thru the publication of research results in peer-review scientific journals by the study investigator. IPD will be made available upon reasonable request from bona fide research organizations in an effort to provide broader impact and enrich public health knowledge. Research volunteer PHI will not be shared, and all participant data will be de-identified and coded. Only encrypted and secure network exchanges will be used for data transfer. Cost sharing my be required in order prepare datasets.

Locations